CLINICAL-APPLICATION OF THE MOLECULAR DIAGNOSIS OF SPINAL MUSCULAR-ATROPHY - DELETIONS OF NEURONAL APOPTOSIS INHIBITOR PROTEIN AND SURVIVALMOTOR-NEURON GENES
Mj. Somerville et al., CLINICAL-APPLICATION OF THE MOLECULAR DIAGNOSIS OF SPINAL MUSCULAR-ATROPHY - DELETIONS OF NEURONAL APOPTOSIS INHIBITOR PROTEIN AND SURVIVALMOTOR-NEURON GENES, American journal of medical genetics, 69(2), 1997, pp. 159-165
The molecular genetic diagnosis of spinal muscular atrophy (SMA) has r
ecently been complicated by the identification of two candidate genes,
which are often deleted in affected individuals but are also occasion
ally deleted in apparently unaffected carriers, We present a compilati
on of genotypes, from our laboratory and recent reports, for the survi
val motor neuron (SMN) and neuronal apoptosis inhibitor protein (NAIP)
genes, Bayesian analyses were used to generate probabilities for SMA
when deletions are present or absent in SMN, We found that when the SM
N(T) exon 7 is deleted, the probability of SIMA can reach greater than
98% in some populations, and when SMN(T) is present, the probability
of SMA is approximately 17 times less than the prior population risk,
Deletion of NAIP exon 5, as well as SMN(T) exon 7, is associated with
a 5-fold increased risk of type I SMA. Case studies are used to illust
rate differing disease risks for pre- and postnatal testing, depending
on the presence of information about clinical status or molecular res
ults, These analyses demonstrate that deletion screening of candidate
genes can be a powerful tool in the diagnosis of SMA. (C) 1997 Wiley-L
iss, Inc.